ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Clinical trials for ESTROGEN RECEPTOR POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ESTROGEN RECEPTOR POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ESTROGEN RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to delay advanced breast cancer growth
Disease control OngoingThis study is testing if adding a drug called palbociclib to the standard treatment helps people with a specific type of advanced breast cancer live longer without their cancer getting worse. It involves 518 adults whose cancer has spread, is HER2-positive, and is also fueled by …
Matched conditions: ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for women with Tough-to-Treat breast cancer
Disease control OngoingThis study is testing whether adding a new oral drug called AZD5363 to a standard hormone therapy (fulvestrant) can better control advanced breast cancer. It is for postmenopausal women whose cancer has grown despite prior hormone-blocking treatments. The goal is to see if this c…
Matched conditions: ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Velindre NHS Trust • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New hormone therapy combinations tested to shrink breast tumors before surgery
Disease control OngoingThis large study compares different hormone therapy approaches given before surgery to shrink breast cancer tumors in postmenopausal women. Researchers are testing whether newer drug combinations work better than the current standard treatment at controlling cancer growth and pre…
Matched conditions: ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New hope for relieving painful side effect of breast cancer treatment
Symptom relief OngoingThis study is testing whether a vaginal estrogen ring or a non-hormonal moisturizer cream works better to relieve vaginal dryness in breast cancer survivors taking anti-estrogen medication. It involves 33 postmenopausal women who have this common side effect. Researchers will tra…
Matched conditions: ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Polly A. Niravath, MD • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC
-
Scanning for clues: can a simple test predict a Cancer's future?
Knowledge-focused OngoingThis study is testing whether special PET scans can predict how well hormone therapy will work for breast cancer that has spread to the bones. Researchers will scan 75 patients before treatment and again at 4 and 12 weeks after starting new therapy. They will compare the scan res…
Matched conditions: ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Blood tests could replace frequent scans for some breast cancer patients
Knowledge-focused OngoingThis study aims to develop a blood test system to monitor advanced breast cancer, potentially reducing the need for frequent CT/MRI scans. It involves 97 patients with ER-positive/HER2-negative metastatic breast cancer who are starting first-line hormone therapy. Researchers will…
Matched conditions: ESTROGEN RECEPTOR POSITIVE BREAST CANCER
Sponsor: The Christie NHS Foundation Trust • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC